Mohamed Anwar Hammad , MPharm (Master of Clinical Pharmacy) - Universiti Sains Malaysia - PhD Candidate (Clinical Pharmacy)

Mohamed Anwar Hammad

MPharm (Master of Clinical Pharmacy)

Universiti Sains Malaysia

PhD Candidate (Clinical Pharmacy)

Pulau Pinang, Penang | Malaysia

Main Specialties: Cardiovascular Disease, Critical Care Medicine, Endocrinology Diabetes & Metabolism, Epidemiology, Geriatric Medicine, Infectious Disease, Internal Medicine, Medical Toxicology, Nephrology, Neurology, Oncology, Pain Medicine, Pharmacology, Preventive Medicine, Psychiatry, Public Health, Pulmonary Disease & Critical Care Medicine, Statistics

Additional Specialties: Clinical Pharmacy

ORCID logo

Top Author

Mohamed Anwar Hammad , MPharm (Master of Clinical Pharmacy) - Universiti Sains Malaysia - PhD Candidate (Clinical Pharmacy)

Mohamed Anwar Hammad

MPharm (Master of Clinical Pharmacy)


Mohamed Anwar Hammad graduated (Bachelor of Pharmaceutical Sciences) from Assiut University, Egypt, in 1997 and completed his Master of Clinical Pharmacy (MPharm) in 2012 from Universiti Sains Malaysia and board certified pharmacotherapy specialist (BCPS) from the American Board of Pharmacy Specialists in 2014. While He started his Ph.D. study at Universiti Sains Malaysia, School of Pharmacy since March 2015. His publications are more than 60 papers in reputed journals.

Primary Affiliation: Universiti Sains Malaysia - Pulau Pinang, Penang , Malaysia


Additional Specialties:

Research Interests:

View Mohamed Anwar Hammad ’s Resume / CV


May 2014
American College of Clinical Pharmacy
Board Certified Pharmacotherapy Specialist BCPS
Board of Pharmacy Specialties
Jul 2010 - Apr 2012
Universiti Sains Malaysia
Master of Clinical Pharmacy - MPharm
Pharmacy School
Sep 1992 - Jun 1997
Assiut University
Bachelor of Pharmaceutical Science
Faculty of Pharmaceutical Sciences
Mar 2015
Universiti Sains Malaysia
PhD Candidate
Pharmacy School - Clinical Pharmacy Depatment


Oct 2012 - Aug 2014
King Khalid University
Clinical Pharmacy Lecturer
Pharmacy School




18Profile Views

Drug-drug Interaction-related Uncontrolled Glycemia.

J Pharm Bioallied Sci 2017 Oct-Dec;9(4):221-228

Department of Pharmacy Practice, Kulliyyah of Pharmacy, International Islamic University Malaysia, Kuantan, Pehang, Malaysia.

View Article

Download full-text PDF

Source Listing
February 2018
15 Reads

Drug-drug Interaction-related Uncontrolled Glycemia

Journal of Pharmacy and Bioallied Sciences

Context: The literature of drug-drug interaction (DDI)-related uncontrolled causality, and preventability of DDI-induced UCG (HbA1c >7%) in outpatients glycemia (UCG) among outpatients with Type 2 diabetes mellitus is still limited. Aims: The aim of this study is to identify the prevalence, mechanism, severity, with Type 2 diabetes. Settings and Design: A cross-sectional study was conducted in Penang General Hospital. Methods: A computerized system for DDI checking was used to assess the severity and mechanism of DDIs. Drug interaction probability scale was used to evaluate the likelihood of DDIs. Preventability of DDIs has been determined by the instrument of Hallas. The UCG prevalence related to DDIs was further assessed. Statistical Analysis Used: SPSS 21.00 was used in this study. Results: From 425 outpatients with HbA1c% test, their mean age was 58.7 ± 12.8 years. Only 225 (52.9%) cases had controlled glycemia while 200 (47.1%) cases with UCG. They had multiple comorbidities, with a mean number of 3.8 ± 2.2/patient and often prescribed with multiple medications, with a mean number of 6.33 ± 4.67/patient. It has been detected that 86 DDIs causing UCG in 46 patients (23%) with range of (1 – 4) DDIs per patient. Drugs with DDI-induced UCG were as follows: diuretics (79%), salbutamol (9.2%), cortisones (5.8%), and others (6%). The majority of these DDIs were categorized as possible (77.9%) and preventable (37%). Conclusion: Nearly one-quarter of UCG was induced by DDIs; most of these DDIs are possible, and more than one-third are preventable. It was concluded that thiazide diuretics have the highest prevalence of DDI-related UCG.

View Article
December 2017
202 Reads